Evidence map›Paper›PMID 40492219›Full record

ArticleEcancermedicalscience2025

The Milan system for reporting salivary gland cytopathology and cyto-histological correlation with special emphasis on cystic lesions-4 years study in a tertiary care institute.

Prateek Das, Nibedita Sahoo, Pranita Mohanty, Pallak Batalia, Ankita Pal

Abstract read
In one paragraph

Article in Ecancermedicalscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Prateek DasDepartment of Oncopathology (Hematopathology), Tata Memorial Centre (HBCH &MPMMCC), Varanasi 221002, UP, India.
Nibedita SahooDepartment of Pathology, IMS and SUM Hospital, Bhubaneswar 751003, India.
Pranita MohantyDepartment of Pathology, IMS and SUM Hospital, Bhubaneswar 751003, India.
Pallak BataliaDepartment of Oncopathology, Tata Memorial Centre Sangrur, Sangrur 148001, India.
Ankita PalDepartment of Pathology, Chirayu Medical College and Hospital, Bhopal 462030, MP, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) was proposed by the American Society of Cytopathology and the International Academy of Cytology to bring uniformity in the reporting and treatment protocol. Cystic component is a common finding in non-neoplastic, benign and malignant lesions of the salivary gland. Fine needle aspiration is challenging in these cases due to pre-analytic error resulting in a high probability of false negativity. Aim: To classify salivary gland lesions according to MSRSGC with special emphasis on cystic lesions and histological correlation. Materials and methods: The study included 214 cases of salivary gland Fine needle aspiration cytology (FNACs) and classified according to MSRSGC with calculation of risk of malignancy (ROM) for each category. Results: The most common age group affected was in the fourth - fifth decade (27.57%) and the common site was parotid gland. The majority of the cases belonged to the Milan category IVA (40.65%) and the least number in categories III and V (4.2%). Histopathology follow up was available in 50% of cases with the maximum number of surgery in category VI (78.5%). The highest ROM was for category VI (90.9%) followed by category V (83.3%). Cystic lesions constituted 22.64%, of which histopathological follow up was available in 64.58% of cases with a high ROM for category III and V(100%). Conclusion: The ROM for cystic lesions is quite high for all categories as compared to the proposed MSRSGC. We suggest that repeat guided FNAC with a rapid on-site evaluation or ancillary diagnostic techniques can increase the diagnostic accuracy, especially for category I, III and cystic lesions.

Indexed as

cystcytologyMilan systemrisk of malignancy

Identifiers

PMID40492219
PMCPMC12146568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.